|
|
|
|
|
|
|
|
1. |
Record Nr. |
UNINA9910438027003321 |
|
|
Titolo |
Non-hodgkin lymphoma : prognostic factors and targets / / Peter J. Quesenberry, Jorge J. Castillo, editors |
|
|
|
|
|
|
|
Pubbl/distr/stampa |
|
|
New York, NY, : Humana Press, c2013 |
|
|
|
|
|
|
|
ISBN |
|
1-299-33548-9 |
1-4614-5851-X |
|
|
|
|
|
|
|
|
Edizione |
[1st ed. 2013.] |
|
|
|
|
|
Descrizione fisica |
|
1 online resource (299 p.) |
|
|
|
|
|
|
Collana |
|
Cancer drug discovery and development |
|
|
|
|
|
|
Altri autori (Persone) |
|
CastilloJorge J |
QuesenberryPeter J |
|
|
|
|
|
|
|
|
Disciplina |
|
|
|
|
|
|
Soggetti |
|
Lymphomas - Risk factors |
Lymphomas |
|
|
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Note generali |
|
Description based upon print version of record. |
|
|
|
|
|
|
Nota di bibliografia |
|
Includes bibliographical references and index. |
|
|
|
|
|
|
Nota di contenuto |
|
Cancer Stem Cells: A Matter of Perspective -- B and T-cell development -- HIV lymphomagenesis -- Epstein-Barr Virus Lymphomagenesis and Therapeutic Targets -- Antigen driven lymphomagenesis -- Pre-clinical lymphoma models -- Prognostic factors in B-cell lymphoma -- Prognostic factors in T-cell lymphoma -- Prognostic factors in HIV-associated lymphoma -- Future directions on the treatment of aggressive non-Hodgkin lymphoma -- New monoclonal antibodies for indolent non-Hodgkin lymphomas -- Current therapies for T-cell lymphoma -- Stem Cell Transplantation for lymphoma -- Autologous stem cell transplantation in non-Hodgkin lymphoma -- The role of Stem Cell Transplantation for HIV-associated lymphoma -- Stem Cell Transplantation for T-cell lymphoma -- Index. |
|
|
|
|
|
|
|
|
Sommario/riassunto |
|
Recent developments in the therapy of non-Hodgkin lymphoma have improved response and survival rates in patients with these conditions. This book is focused on the biology, prognostic factors and novel targets of non-Hodgkin lymphoma. We believe that understanding the pathophysiology of non-Hodgkin lymphoma provides a mean to improve its risk-stratification and treatment. This book is intended for medical and healthcare professionals involved in the research and clinical care of patients with non-Hodgkin lymphoma. |
|
|
|
|
|
|
|